|
Brawn Biotech Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
6.24 Cr.
|
P/BV
|
1.66
|
Book Value (Rs.)
|
12.52
|
|
52 Week High/Low (Rs.)
|
24/16
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
18/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -5.68 | -4.15 | -3.04 | -5.25 | -1.55 |
| Diluted EPS (Rs.) | -5.68 | -4.15 | -3.04 | -5.25 | -1.55 |
| Cash EPS (Rs.) | -5.42 | -3.83 | -2.53 | -5.30 | -1.72 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 |
| Revenue From Operations / Share (Rs.) | 44.88 | 54.98 | 74.09 | 28.73 | 116.57 |
| PBDIT / Share (Rs.) | -5.60 | -4.80 | -0.98 | -6.67 | -0.96 |
| PBIT / Share (Rs.) | -5.98 | -5.13 | -1.34 | -6.85 | -1.08 |
| PBT / Share (Rs.) | -5.99 | -5.15 | -1.37 | -7.06 | -1.20 |
| Net Profit / Share (Rs.) | -5.80 | -4.16 | -2.89 | -5.48 | -1.84 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -12.47 | -8.73 | -1.32 | -23.22 | -0.82 |
| PBIT Margin (%) | -13.32 | -9.33 | -1.81 | -23.84 | -0.92 |
| PBT Margin (%) | -13.35 | -9.36 | -1.85 | -24.56 | -1.02 |
| Net Profit Margin (%) | -12.92 | -7.56 | -3.90 | -19.07 | -1.57 |
| Return on Networth / Equity (%) | -51.75 | -24.61 | -13.75 | -22.77 | -6.26 |
| Return on Capital Employeed (%) | -16.07 | -19.06 | -6.21 | -27.53 | -3.60 |
| Return On Assets (%) | -8.49 | -8.54 | -5.97 | -11.92 | -3.96 |
| Asset Turnover Ratio (%) | 0.76 | 1.13 | 1.57 | 0.62 | 2.05 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.88 | 2.02 | 1.67 | 1.93 | 2.60 |
| Quick Ratio (X) | 0.75 | 1.09 | 1.07 | 1.18 | 2.54 |
| Inventory Turnover Ratio (X) | 1.63 | 0.00 | 0.00 | 0.00 | 5.09 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -459.48 | -380.33 | -35.76 | -32.06 | -7.83 |
| Interest Coverage Ratio (Post Tax) (%) | -474.95 | -328.11 | -104.52 | -25.33 | -13.91 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 4.68 | 5.60 | 4.53 | 4.98 | 6.23 |
| EV / Net Operating Revenue (X) | 0.34 | 0.33 | 0.20 | 0.57 | 0.17 |
| EV / EBITDA (X) | -2.78 | -3.89 | -15.39 | -2.49 | -21.54 |
| MarketCap / Net Operating Revenue (X) | 0.36 | 0.36 | 0.22 | 0.60 | 0.18 |
| Price / BV (X) | 1.45 | 1.18 | 0.78 | 0.72 | 0.75 |
| Price / Net Operating Revenue (X) | 0.36 | 0.36 | 0.22 | 0.60 | 0.18 |
| EarningsYield | -0.35 | -0.20 | -0.17 | -0.31 | -0.08 |
